FRI0228 Sarilumab Dose Reduction To Manage Laboratory Abnormalities in An Open-Label Extension Study in RA Patients
Genovese, M.C., Fay, J., Parrino, J., Garg, A., van Hoogstraten, H., Boddy, A., Martincova, R., Graham, N., Simon, J., Burmester, G.R.Volume:
75
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2016-eular.3709
Date:
June, 2016
File:
PDF, 156 KB
english, 2016